France vs Switzerland: Share of E. coli infections resistant to cephalosporins
France
9.1%
in 2022
Switzerland
9.8%
in 2022
France rank
41st
Switzerland rank
39th
Share of E. coli infections resistant to cephalosporins over time
- France
- Switzerland
How they compare
Switzerland currently reports 9.8% against 9.1% in France, a difference of 0.7%.
That makes Switzerland's figure about 1.1 times France's.
The two have swapped places 1 time across 6 shared years of data; in 2017 it was France ahead.
France ranks 41st and Switzerland ranks 39th of 46 countries.
Switzerland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | France | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 9.6% | 10.0% | 0.4% | Switzerland |
| 2020s | 9.5% | 10.1% | 0.7% | Switzerland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, France or Switzerland?
- Switzerland, at 9.8% against 9.1% in France as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between France and Switzerland?
- 0.7%, with Switzerland ahead.
- How many years of comparable data are there for France and Switzerland?
- 6 years are reported by both, from 2017 to 2022.
- How do France and Switzerland rank globally for share of e. coli infections resistant to cephalosporins?
- France ranks 41st and Switzerland ranks 39th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).